Interestingly, we detected a significant increase in the CD38+CD8+ effector memory and TEMRA T cell population in the moderate/severe COVID-19 HD cohort, which was not the case in the COVID-19 non-HD patients (Figures 4A–D). This evidence concerns the gene CD8A and COVID-19.